Digital therapeutics take a 21st century approach to medicine, so why shouldn't the way their clinical trials are run? For therapy on your smartphone, it wouldn't make sense to go to a doctors office multiple times to fill out a bunch of handwritten paperwork, does it?

The unique make up of digital therapeutics, harnessing the technology around us, makes for a perfect recipe to collect lots of meaningful clinical data with an easy digital approach. In this webinar Curebase will explore 3 case studies of digital therapeutic clinical trials that showcase, in contrast to copying and pasting drug study approaches from the 1990s, how technology driven clinical operations were used to maximize the potential of data coming out of a digital therapeutic trial.

Explore with us how digital therapeutics present unique opportunities in clinical trial digital recruitment, virtual visits, remote collection of endpoints, device integrations, remote monitoring, and more.

‍

About Curebase
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.  

This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. 

We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News!